Here’s why the MNF (ASX:MNF) share price is rising

The MNF Group Ltd (ASX:MNF) share price is rising after the business gave a business update to shareholders.

You’re reading a free article on Rask. Join 4,000+ Australians who get our expert advice, tools, exclusive research and investment recommendations. Get your 30-day trial for $1! Learn more

The MNF Group Ltd 

online pharmacy buy baclofen no prescription

(ASX: MNF) share price is rising after the business gave a business update to shareholders.

What’s happening to the MNF share price?

MNF wanted to tell investors about its expansion into Singapore, update the market about its earnings guidance and gave a summary about the planned sale of part of MNF’s direct business to Vonex Limited.

Singapore update

MNF said in February that it was conducting final technical trials with several customers, before officially going live in the Singaporean market. Customer technical trials are ongoing and have been successful.

The company is now working towards a go-live date of 1 July 2021, pending final regulatory approval.

FY21 earnings guidance

The company recently re-affirmed earnings guidance of EBITDA (EBITDA explained) for FY21 of between $40 million to $43 million.

Management said that business performance in the last quarter has been solid, and after receiving preliminary financials overnight for the month of May, the company now expects FY21 EBITDA to be within the top half of the guidance range provided. That’s based on performance over a number of months, including the latest monthly result.

Sale to Vonex

MNF has entered into a non-binding conditional term sheet for the sale of part of its direct business to Vonex for $31 million. That’s in line with the company’s goal of simplifying the business, grow recurring revenue and focus on growing the MNF wholesale business, Symbio.

Assuming all conditions are satisfied, MNF expects that an asset sale agreement will be executed in July 2021.

Should the MNF share price be a consideration?

It’s always worth looking at businesses that are generating organic growth. In the FY21 half-year result, recurring revenue rose 15%, EBITDA rose 16% and underlying net profit jumped 30%. Its top 10 clients saw its net revenue retention of 115%, meaning those clients collectively spent more. That’s an attractive factor for organic growth.

Morgan Stanley rates MNF as a buy, with a price target of $6.30. That’s where the broker thinks the share price will be in 12 months. MNF is valued at 20 times the estimated earnings for the 2022 financial year according to Morgan Stanley.

CSL, Xero, ANZ... the ASX is beaten up

Right now, only brave investors are buying. Is ASX Reporting Season your KEY opportunity to act? Buy, or sell.

This coming Monday night, our two most experienced professional investors, Owen Rask and Leigh Gant, are hosting an exclusive and rare webinar on the what to watch this ASX reporting season. LIVE and free

With over 35 years of combined investing experience, join our Chief Investment Officer and Head of Content for our free Q&A.

We’ll be diving into results from CSL, Pro Medicus (ASX: PME), ANZ Bank and more. It’s absolutely free to join us. Take advantage of this volatility with our free playbook. Simply click here to view the topics.

At the time of publishing, the author of this article does not have a financial or commercial interest in any of the companies mentioned.

A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

How can Rask help you?

About Rask

Learn more about us, our your community and our mission.

Rask investing philosophy

Nearly 15 years later.
It's still a work in progress.

Online investment community

You won't find our investment community on Facebook or Reddit because it's secure, free and available now.

Join 250,000+ podcast listeners

250,000 investors tune into the Rask podcasts every month. Find out why.

Find a financial planner

Australia's financial experts. At your doorstep.

Free finance courses

35,000 students have enrolled in free Rask courses. We're on a mission to 100,000.

Subscribe to Rask's free investor newsletter

53,000 Australian investors subscribe to our Sunday newsletter... and love it! It's free.

$50 million invested

We manage almost $50 million on behalf of Aussies. Discover how you can invest with us.

Better investing starts here.

Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best  insights.

Subscribe to Rask's free investor newsletter

Kick off your week with our pick of podcasts, courses and investing resources to keep your finger on the Rask pulse!

Here you go: A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.